RE: Question?11 Feb 2021 14:12
Sorry Jaylarc I have now read your comment properly and can see your point however, I read
‘
The Company anticipates that the above actions will provide the Company with capacity to produce approximately 2 million tests per week by the end of April, when combining the Government-loaned equipment with its own manufacturing equipment. Omega expects that this capacity will be sufficient to meet the expected demand for lateral flow COVID-19 antigen tests, with enough remaining capacity to be used for VISITECT® CD4 or COVID-19 antibody tests according to demand.’
as 2m per week for the Govt. plus whatever we can sell via VISITECT and antibody tests which we started to gear up for in the first place. Let’s see, I am sure it will all become clear soon.